维普中文期刊产品整合服务
34篇 您的检索式:作者名="Chrystyn H"
    题名 作者 年代 出处 被引量
1Closer to an 'ideal inhaler' with the Easyhaler: an innovative dry powder inhaler显示文摘CHRYSTYN H 2006Clin Drug Investig2006,26,4:1
2Determination of gentamicin in urine samples after inhalation by reversed phase high-performance liquid chromatography using preccolumn derivatisation with o-phthalaldehyde显示文摘Al-Amoud AI Clark BJ Chrystyn H 2002J Chromatogr B Analyt Technol Biomed Life Sci2002,769,1:1
3Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis:a pilot study显示文摘Crowther Labiris NR Holbrook AM Chrystyn H 1999Am J Respir Crit Care Med1999,160,5:1
4Determination of gentamiein in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehyde 显示文摘AL-AMOUD A I CLARK B J CHRYSTYN H 2002J Chromatogr B2002,769,:1
5Methods to identify drug deposition in the lungs following inhalation显示文摘Chrystyn H 2001Br J Clin Pharmacol2001,51,4:1
6Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailabilty to the lung 显示文摘Hindle M Chrystyn H 1993Thorax1993,48,6:1
7Determination of the Relative Bioavailability of Salbutamol to the Lungs and Systemic Circulation Following Nebulization Br显示文摘Silkstone VL Corlett SA Chrystyn H 2002J Clin Pharmacol2002,54,2:1
8Determination of the relative bioavailability of salbutamol to the lung following inhalation显示文摘Hindle M Chrystyn H 1992Br J Clin Pharmacol1992,34,4:1
9Closer to an ' Ideal Inhaler' with the Easyhaler: an innovative dry powder inhaler 显示文摘CHRYSTYN H 2006Clin Drug Invest2006,26,4:1
10Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol(BF) in COPD: An in-vitro comparison of spiromax with turbuhaler显示文摘Chrystyn H Safioti G Keegstra JR 2015Int J Pharm2015,491,12:1
11Closer to an 'ideal inhaler' with the Easyhaler:an innovative dry powder inhaler显示文摘Chrystyn H 2006Clin Drug Investig2006,26,4:1
12Standards for bioequivalence of inhaled products 显示文摘 1994Clin Pharmacokinet1994,26,1:1
13Development and Validation of HPLC Method for the Determination of Tobramycin in Urine Samples Post-inhalation Using Pre-column Derivatisation with Fluorescein Isothiocyanate显示文摘MASHAT M CHRYSTYN H CLARK B J 2008J Chromatogr B2008,869,:1
14Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD 显示文摘Chrystyn H Small M Milligan G 2014Respir Med2014,108,2:1
15New HPLC assay for urina- ry salbutamol concentrations in samples collected post inha lation显示文摘Mazhar S H R A Chrystyn H 2009J Pharm Biomed Anal2009,50,:1
16Standards for bioequivalence of inhaled products 显示文摘CHRYSTYN H 1994Clin Pharmacokinet1994,26,1:1
17New HPLC assay for urinary salbutamol concentrations in samples collected post-inhalation显示文摘Mazhar S Chrystyn H 2009Journal of Pharmaceutical and Biomedical Analysis2009,50,2:1
18Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehyde显示文摘Al-Amoud A I Clark B J Chrystyn H 2002J Chromatogr B Analyt Technol Biomed Life Sci2002,769,1:1
19In-vitro intra- and inter-inhaler flow ratedependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler 显示文摘TARSIN W ASSI K H CHRYSTYN H 2004J Aerosol Med2004,17,1:1
20Development and validation of an ion-pair liquid chromatographic method for the quantification of sodium cromoglycate in urine following inhalation 显示文摘Aswania OA Corlett SA Chrystyn H 1997J Chromatogr B1997,690,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费